1. Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
   Wenwei Yang et al, 2021, OncoTargets and Therapy CrossRef
2. Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers
   Khine S. Shan et al, 2024, International Journal of Molecular Sciences CrossRef
3. Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives
   Francesca Corti et al, 2019, Cancer Treatment Reviews CrossRef
4. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
   Hongyang Lu et al, 2018, BMC Cancer CrossRef
5. mTOR Inhibitors in Advanced Biliary Tract Cancers
   Chao-En Wu et al, 2019, International Journal of Molecular Sciences CrossRef
6. Genomic landscape and tumor mutation burden analysis of Chinese patients with sarcomatoid carcinoma of the head and neck
   Hai-bing Chen et al, 2021, Oral Oncology CrossRef
7. Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma
   Changhee Park et al, 2021, Cancer Research and Treatment CrossRef
8. Correlation between RICTOR overexpression and amplification in advanced solid tumors
   Heejin Bang et al, 2020, Pathology - Research and Practice CrossRef
9. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
   Mirella Pastore et al, 2020, Cells CrossRef
10. Transcriptomics analysis of sirolimus treatment in lupus nephritis
    Dongdong Wang et al, 2019, Molecular Medicine Reports CrossRef
11. The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions
    Ayda Baghery Saghchy Khorasani et al, 2021, European Journal of Pharmacology CrossRef
12. Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling
    Renshen Xiang et al, 2021, Stem Cell Research & Therapy CrossRef
13. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT)
    Umberto Cillo et al, 2024, Updates in Surgery CrossRef
14. TMEM16A partners with mTOR to influence pathways of cell survival, proliferation, and migration in cholangiocarcinoma
    Sucheta Kulkarni et al, 2023, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
15. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA
    Xianbiao Shi et al, 2021, Experimental Cell Research CrossRef